Concerns following event on HAVEN1 trial.
Tafinlar and Mekinist looks set for approval in BRAF V600 lung cancer
This week’s news
Roche rival has Breakthrough Therapy status.
Four in ten EEA doctors considering quitting, says survey.
Company looking to smartwatch and health markets as next step.
Activist investor’s intervention adds to buzz surrounding BMS.
Results mean patients could switch to once-daily inhaler use
Cognition Kit wearable app measures daily activities and tests cognitive function.
More rare disease drugs must also be approved, says EURORDIS.
Roche’s top seller faces rival four years after patent expiry
Initiative will focus on AI and cloud-based tools to help ‘empower people to lead healthier lives.’
Antibody-drug conjugate with FDA gets six-month review.
Biotech looks for funding and long-term development partner
Alecensa part of Roche’s goal of becoming dominant player in NSCLC
Government hopes spaceport plans will boost biotech research
Partnership will help better inform care decisions made between doctors and patients.